Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia

  • Home
  • 2020
  • September
  • 1
  • U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia

Original Source

On September 1, 2020

Post navigation

Previous PostBristol Myers Squibb Announces Interim Results from Long-Term Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis
Next PostBristol Myers Squibb to Participate in Citi’s 15th Annual BioPharma Virtual Conference

Related Post

May 24, 2022
  • Business News
  • Press Release

Apple expands Today at Apple Creative Studios

May 24, 2022
  • Business News

Western Union to Present at the Bernstein Strategic Decisions Conference on June 2nd

May 24, 2022
  • Business News

Incyte to Present at Upcoming Investor Conference

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219